Last reviewed · How we verify
NCT05278442
Evaluation of the Accuracy & Safety of the LaserArcs Nomogram
trial testing LaserArc in Cataract in 50 participants. Completed in 8 August 2022.
7 August 2022
Quick facts
| Lead sponsor | Research Insight LLC |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 50 |
| Start date | 1 April 2022 |
| Primary completion | 7 August 2022 |
| Estimated completion | 8 August 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- LaserArc
Conditions studied
- Cataract — all drugs for Cataract →
- Astigmatism — all drugs for Astigmatism →
Sponsor
Research Insight LLC — full company profile →
Who can join
22 and older, any sex, with Cataract or Astigmatism. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Evaluation of the Accuracy and Safety of the LaserArcs Femtosecond Cataract Surgery Arcuate Incision Nomogram in Patients Undergoing Cataract Surgery and Astigmatism Reduction
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05278442
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cataract
Currently open trials in the same condition.
- NCT07301385 — Evaluation of Head-Mounted Spatial Computing and Three-Dimensional (3D) Visualization in Ocular Microsurgery: A Safety a · NA · recruiting
- NCT07462000 — Aqueous Humor and Ocular Tissue Analysis in Glaucoma and Cataract · NA · recruiting
- NCT06891092 — Vivinex Impress XY1-EM vs RayOne EMV · NA · recruiting
- NCT07218796 — Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compar · Phase 3 · recruiting
- NCT07218783 — Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compar · Phase 3 · recruiting
Other Research Insight LLC trials
Trials by the same sponsor.
- NCT07276802 — The TRIBECA Study (TRIessence/Byqlovi for Easier CAtaract Surgery) · Phase 4 · not yet recruiting
- NCT07144644 — 2311 TURGOR Study -Surgical Efficiency and Postoperative Corneal Clarity With Near Physiologic vs High IOP Settings · completed
- NCT06482164 — The THINK Study Incidence of Neurotrophic Keratopathy) · NA · completed
- NCT06482177 — The COAT Trial: Cequa's Onset of Action Trial · Phase 4 · completed
- NCT05346172 — The Clareon PanOptix Trifocal IOL: Visual Outcomes and Patient Satisfaction · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05278442 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Research Insight LLC
- Last refreshed: 1 November 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05278442.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing